期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

洛铂治疗肿瘤的研究进展 被引量：2

Progression of Iobaplatin for cancer
原文传递
导出
摘要 洛铂是第3代铂类抗肿瘤药物。大量临床前药效学研究显示，洛铂能阻断细胞周期的运行，诱导细胞凋亡，从而有效抑制肿瘤细胞增殖，且与顺铂无交叉耐药性。洛铂对多种肿瘤患者亦有较好的疗效，且不良反应轻微，安全性较好。 Lobaplatin is the third generation platinum drug. Many studies on pharmacodynamics have confirmed that lobaplatin can block the cell cycle and induce cell apoptosis, and thus inhibits tumor cell prolifeeration effectively. Lobaplatin is not cross-resistant to cisplatin. Besides, it has good curative effect to various kinds of cancer patients with mild adverse reactions, and the patients are well tolerable to it.
作者 孙娜 杨文燕
机构地区 山东省医学科学院山东省医药卫生科技信息研究所
出处 《国际肿瘤学杂志》 CAS 2012年第12期907-909,共3页 Journal of International Oncology
关键词 肿瘤 药效学 临床研究 洛铂 Neoplasms Pharmacodynamics Clinical research Lobaplatin
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Zhang J, Liu D, Li Y, et al. Status of non-classical mononuclear platinum anticancer drug development. Mini Rev Med Chem, 2009, 9 (11) : 1356-1366.
  • 2史健,袁志芳,刘伟娜,郭芳,单保恩,王贵英,刘江,鲁壮平,张俊珍,王永利.国产注射用洛铂在恶性肿瘤患者体内药动学的研究[J].中国药学杂志,2007,42(24):1888-1891. 被引量：21
  • 3Alami NZ, Li ZH, Engel JG, et al. Comparative preclinical anti-pro- liferative activity of lobaplatin vs cisplatin, carboplatin, oxaliplatin and satraplatin in breast and ovarian cancers. Proceeding of the 98th AACR Annual Meeting, Los Angeles: CA, 2007: a4780.
  • 4刘萍萍,张灿珍,王羽丰.洛铂诱导顺铂耐药卵巢癌SKOV3/DDP细胞的凋亡[J].肿瘤防治研究,2007,34(11):829-832. 被引量：18
  • 5Xie CY, Xu YP, Jin W, et al. Antitnmor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung canc- er. Anticancer Drugs, 2012, 23(7): 698-705.
  • 6Dai HY, Liu L, Qin SK, et al. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro. Biomed Pharmacother, 2011, 65(3) : 137-141.
  • 7Luo J, Guo RP, Lai EC, et al. Transarterial chemoembolization for unreseetable hepatocellular carcinoma with portal vein tumor thrombo- sis: a prospective comparative study. Ann Surg Oncol, 2011, 18 (2) : 413-420.
  • 8Engel JB, Martens T, Hahne JC, et al. Effects of lobaplatin as a sin- gle agent and in combination with TRAIL on the growth of triple-nega- tive p53-mutated breast cancers in vitro. Anticancer Drugs, 2012, 23 (4) : 426-436.
  • 9Kirpensteijn J, Teske E, Kik M, et al. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase Ⅱ evaluation. Anticancer Res, 2002, 22(5): 2765-2770.
  • 10Ye QS, Lou LG, Liu WP, et al. Synthesis and in vitro cytotoxicity of novel lipophilic (diamine) platinum( Ⅱ ) complexes of salicylate derivatives. Bioorg Med Chem Lett, 2007, 17(8) : 2146-2149.

二级参考文献25

  • 1栗宝华,胡东晓,赵丽嫣.体外培养人卵巢癌细胞株SKOV-3、SKOV-3/DDP并探讨卵巢癌顺铂耐药机制[J].中国妇幼保健,2005,20(10):1195-1197. 被引量：6
  • 2殷玉志,陈珊珊.乐铂对HL－60细胞程序化死亡诱导作用研究[J].北京医科大学学报,1995,27(3):173-175. 被引量：3
  • 3Aetema Laborries. Lobaplatin ( D-19466 ) [ J ] . Drugs R & D, 2003, 4 (6): 369.
  • 4Aetema Laborries. Lobaplatin (D-19466) [J]. DrugsR&D, 2003,4(6) :369-372.
  • 5Harstrick A, Bokemever C, Scharnofkse M, et al. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitire and resistant human testicular, ovarian, and gastric carcinoma cell lines[J]. Cancer Chemother Pharmacol, 1993, 33 ( 1 ) : 43-47.
  • 6Meijer C, Mulder NH, Timmer-Bosseha H, et al. Relationship of cellular glutathione to the eytotoxieity and resistanee of seven platinum eompounds [J].Caneer Res, 1992,52 (24) : 6885- 6889.
  • 7Harstrick A, Vanhoefer U, Heidemann A, et al. Drug interactions of 5-fluorouracil with either cisplatin or lobaplatin -a new, clinically active platinum analog in established human cancer cell lines[J]. Anticancer Drugs, 1997,8(4):391-395.
  • 8Montague JW,Cidlowski JA. Cellular catabolism in apoptosis: DNA degradation and endonuclease activation[J]. Experientia, 1996,52(10-11):957-962.
  • 9Beale PJ, Rogers P, Boxall F, et al. Bcl-2 family protein expression and platinum drug resistanee in ovarian carcinoma[J]. Br J Cancer, 2000,82 (2) : 436-440.
  • 10HARSTRICK A, ItAPKE G, SCHARNOFSKE M, et al. High activity of lobaplatin in Cisplatin resistant human carcinoma cell lines cell lines in vitro and in vivo [ J ]. Proc AM Assoc Cancer Res, 1993,34:403.

共引文献38

同被引文献9

引证文献2

二级引证文献8

国际肿瘤学杂志
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部